Deridder, 70634, LA,
United States
Aerie Pharmaceuticals, Inc. Technographics
Aerie Pharmaceuticals, Inc. Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Aerie Pharmaceuticals, Inc. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 371 Aerie Pharmaceuticals, Inc. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Aerie Pharmaceuticals, Inc. has purchased the following applications: Microsoft 365 for Collaboration in 2017, Amazon EC2 for Application Hosting and Computing Services in 2020, Okta Identity Cloud for Identity and Access Management (IAM) in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Aerie Pharmaceuticals, Inc. is running and its propensity to invest more and deepen its relationship with Microsoft , Amazon Web Services (AWS) , Okta or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Aerie Pharmaceuticals, Inc. revenues, which have grown to $72.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Aerie Pharmaceuticals, Inc. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Aerie Pharmaceuticals, Inc. Tech Stack and Enterprise Applications
Aerie Pharmaceuticals, Inc. Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2017 | 2017 |
In 2017, Aerie Pharmaceuticals, Inc. implemented Microsoft 365 to provide Collaboration across its corporate environment. The deployment is surfaced on the company website, indicating that Microsoft 365 services are used for both internal collaboration and for supporting external-facing content workflows tied to corporate communications.
The Microsoft 365 implementation centers on Collaboration capabilities including messaging, document management, file synchronization, and team collaboration, consistent with Exchange Online, SharePoint Online, OneDrive, and Microsoft Teams functionality. Operational scope targets corporate business functions such as communications, knowledge management, and cross-functional team collaboration across the organization, and governance likely aligns to centralized identity, account provisioning, and content governance practices to control access and publishing.
|
Aerie Pharmaceuticals, Inc. IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Amazon Web Services (AWS) | Legacy | Amazon EC2 | Application Hosting and Computing Services | IaaS | n/a | 2020 | 2020 |
In 2020, Aerie Pharmaceuticals, Inc. implemented Amazon EC2 to host its public website. The Amazon EC2 deployment is categorized under Application Hosting and Computing Services and provides the primary compute layer for the company web presence.
The implementation centers on Amazon EC2 compute instances running web server workloads and leverages category aligned capabilities such as instance provisioning, Amazon Machine Images, security group network controls, and lifecycle automation for patching and instance orchestration. Operational scope focuses on the external website and customer facing digital channels, influencing marketing and digital operations, while governance is organized around AWS identity and access management, instance tagging, and provisioning workflows to control capacity and permissions across the corporate AWS account.
|
|
|
|
|
Content Delivery Network | IaaS |
|
2018 | 2018 |
|
Aerie Pharmaceuticals, Inc. CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Okta | Legacy | Okta Identity Cloud | Identity and Access Management (IAM) | CyberSecurity | n/a | 2021 | 2021 |
In 2021, Aerie Pharmaceuticals, Inc. implemented Okta Identity Cloud to provide centralized authentication for its public website. The Okta Identity Cloud deployment is an Identity and Access Management (IAM) implementation that centralizes single sign-on for web access and clarifies the relationship between Aerie Pharmaceuticals, Inc., Okta Identity Cloud, and the Identity and Access Management (IAM) business function.
The deployment centers on Okta SSO integrated into the website authentication flow, leveraging core Identity and Access Management (IAM) capabilities such as centralized authentication, access policy enforcement, and federation for web sessions. Configuration emphasizes SSO session management, authentication flows, and policy-driven access controls, while governance concentrates authentication and access policies within the Okta Identity Cloud tenant.
|
IT Decision Makers and Key Stakeholders at Aerie Pharmaceuticals, Inc.
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Aerie Pharmaceuticals, Inc. Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||